Mindblown: a blog about philosophy.
-
Insider Buying Signals Confidence in these 3 Stocks
Insider buying in consumer stocks like Robinhood, Hims & Hers Health, and NCLH signals growing management confidence.
-
3 Down-and-Out Consumer Stocks To Buy on Sector Rotation
Consumer stocks Nike, Starbucks, and Target are quietly rebuilding momentum and could benefit as investors look beyond AI stocks.
-
SpaceX Mania Is Here: Two ETFs are Benefiting from the Boom
SpaceX stock has surged since its IPO, but FPX and IPO ETFs may offer a lower-risk way to profit from the new stock boom.
-
3 High P/E Stocks Worth Buying for the Long Haul
High P/E stocks are still worth buying if earnings growth is outrunning their valuation. For these stocks, a premium multiple won’t stay premium for long.
-
Micron’s AI-Fueled Rally Shows No Signs of Slowing—But Risks Remain
Micron’s AI-driven rally faces rising caution as memory shortages, high expectations, and cyclical risks build ahead of earnings.
-
Could SpaceX’s IPO Change The Way Your Retirement Money Is Invested?
Nasdaq cut its IPO seasoning period from 90 to 15 days, speeding SpaceX’s index entry and raising concerns for passive investors.
-
3 of the Most Undervalued Stocks to Own Today
Undervalued stocks like Nvidia, Oracle, and Lowe’s may offer investors attractive opportunities to own quality stocks at lower prices.
-
AbbVie vs. JNJ: Which Biopharma Stock Wins in 2026?
Biopharma stocks may benefit from sector rotation. AbbVie and Johnson & Johnson deserve a close look, but they are not the same trade.
-
Adobe Beats Earnings and Raises Guidance. Why the Stock Is Falling Anyway.
The market ignored record revenue and AI-driven growth, focusing instead on the uncertainty surrounding Adobe’s leadership transition.
-
CrowdStrike Delivers Strong Growth, But Investors Wanted More
The business keeps growing, AI demand keeps rising, and ARR keeps expanding. The problem wasn’t performance. It was expectations.
Got any book recommendations?